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STUDIES were carried out to evaluate the impact of a
high-fat dietary regimen on aortic wall thickness,
peripheral blood leukocyte profile, and plasma cho-
lesterol and triglyceride levels in the mast cell-
deficient Sl/Sl
d mouse. The results demonstrated
that the mean aortic wall thickness of Sl/Sl
d mice
was significantly higher than their normal litter-
mates, and were increased in both genotypes after a
17-day high-fat regimen. In comparison with normal
littermates, Sl/Sl
d genotypes had elevated levels of
plasma triglycerides with normal levels of plasma
cholesterol, and the high-fat diet markedly lowered
the triglyceride levels. Total peripheral blood leuko-
cytes, the monocyte and granulocyte counts, and
hemoglobin levels were significantly lower in Sl/Sl
d
mice, although the number of lymphocytes, eosino-
phils and basophils were the same in both genotypes.
Interestingly, the high-fat diet regimen elevated
leukocyte counts and the number of monocytes and
granulocytes in Sl/Sl
d mice.
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Introduction
The pathogenesis of atherosclerosis shares many
features of the inflammatory response and is char-
acterized by endothelial cell activation, infiltration of
inflammatory cells, accumulation of macrophages
and mast cells, and proliferation of smooth muscle
cells.
1,2 Mast cells are important cells of the innate
immune system and play a role in mediating the
pathophysiology of many inflammatory diseases.
Mast cells are strategically located in the vessel wall
and release many inflammatory mediators upon their
activation. These include histamine, prostaglandin
D2, leukotrienes, heparin, and a variety of cytokines,
and proteases.
3 7 Although mast cells are primarily
known for their role in the development of hyper-
sensitivity reactions, strong evidence implicates this
cell type in the progression of atherosclerosis. The
presence of an increased number of mast cells in
atherosclerotic lesions,
8 12 atheromas,
13 and in the
adventitia of coronary arteries with plaques
14,15
supports this concept. In addition, thrombus forma-
tion is associated with an increase in the number of
mast cells in the arterial wall.
8 The participation of
mast cells in vascular physiology is further supported
by the localization of mast cell granules within
endothelial cells in vivo
16 and by the ability of mast
cell granules to induce proliferation of human
microvascular endothelial cells.
17 The localization
of mast cells in the human heart
12 and the recognition
of mast cell chymase as a factor in the generation of
angiotensin II
7,18 support the role of mast cells in
both myocardial and vascular function.
Disorders in lipid metabolism are major risk factors
for the development of atherosclerosis. According to
this hypothesis, modified low-density lipoprotein
(LDL) is taken up by endothelial cells, macrophages
and smooth muscle cells. In the subendothelial
space, modified LDL can act as a chemoattractant
for monocytes that adhere to the endothelium,
migrate into subendothelial space and become
macrophages that transform into foam cells by
uptake of altered LDL. Mast cell granule proteases
have been shown to modify LDL and enhance their
uptake by macrophages with transformation to foam
cells,
13,19 suggesting a role for the mast cell in lipid-
related atherosclerosis.
The Steel /Dickie Sl/Sl
d mouse is mast cell deficient
due to a mutation by which the transmembrane and
cytoplasmic domains of stem cell factor (SCF) are
deleted. It is well recognized that SCF is essential for
mast cell differentiation and maturation, as well as for
granulopoiesis.
20,21 The present study was designed
to determine the relative atherogenic potential of a
high-fat regimen in normal and Sl/Sl
d mice with the
focus of understanding the role of mast cells in
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335atherosclerosis. The results of the present study
demonstrate that the aortic wall thickness of mast
cell-deficient Sl/Sl
d mice is significantly higher than
normal controls, when adjusted for body weight, and
was increased in both genotypes after the high-fat
regimen. Furthermore, in comparison with normal
littermates, mast cell-deficient genotypes have ele-
vated levels of plasma triglycerides without altered
levels of plasma cholesterol. The results revealed that
the atherogenic high-fat diet increased the aortic wall
thickness, increased plasma cholesterol and lowered
triglyceride levels in both Sl/Sl
d and normal mice. In
addition, the mast cell-deficient mice partially cor-
rected their defective erythropoiesis, and both Sl/Sl
d
and their normal littermates demonstrated increased
granulopoises after the high-fat regimen.
Material and methods
Animals and diet
The 5-week-old to 6-week-old female Sl/Sl
d mice and
the normal littermates used in the study were of
C57BL/6 lineage and were obtained from Jackson
Laboratories (Bar Harbor, ME, USA). The control
diet was Purina Breeder Chow whereas the high-
fat diet was prepared by mixing a diet containing
30% cocoa butter, 5% cholesterol, 2% sodium cholate,
30% casein, 5% aphacel, 4% vitamin mixture, 6.5%
sucrose, 6.5% dextrin and 0.5% cholic acid with
Purina Breeder Chow in a ratio of 1:3 parts (w/w),
respectively, and then pelleted (Harlan-Teklad,
Madison, WI, USA). Diagnostic enzyme kits for
determination of total plasma cholesterol and trigly-
cerides were obtained from Sigma (St Louis,
MO, USA).
Animal treatment
Sixteen Sl/Sl
d mast cell-deficient mice and 16 C57BL/
6 mice were used in this study. Eight animals from
each genotype were randomized into each of the two
dietary regimens, ‘normal diet’ and ‘high-fat diet’. The
animals in the ‘normal diet’ group were fed the
standard mouse chow while those in the ‘high-fat
diet’ were given a high-fat, high-cholesterol diet for
17 weeks. The animals were housed in a tempera-
ture-controlled (228C) facility throughout the dura-
tion of the experiment, and were provided free
access to food and water. The initial and final body
weights of all animals were recorded. At the end of
the experimental protocol, all animals were eutha-
nized by Halothane inhalation prior to the harvest of
tissues. All procedures employed in this study were in
accordance with the institution’s guidelines for care
and use of laboratory animals and the protocols were
approved by Laboratory Animal Research Committee
of the University of Kansas Medical Center.
Blood and tissue sampling
Seventeen weeks after the start of the study animals
were anesthetized with metaphane and blood sam-
ples were collected from each mouse using the retro-
orbital sampling technique into heparinized capillary
tubes. In addition, blood smears were prepared for
total and differential counts of leukocytes.
Plasma lipid analysis
Blood samples collected in heparinized capillary
tubes were immediately centrifuged, the plasma
removed, and were frozen at   /808C until the time
of analysis. Plasma samples were assayed for total
cholesterol and triglycerides using standard enzy-
matic assay kits according to the manufacturer’s
instructions. The concentrations of cholesterol in
the serum were measured by a colorimetric assay.
22
Triglyceride levels in the plasma were assayed with
ultraviolet detection at 340 nm as described else-
where.
23 All plasma lipid analyses were performed in
duplicate.
Histology
After exsanguination, the heart with 1 /1.5 cm of
ascending thoracic aorta was dissected and rinsed
with cold phosphate-buffered saline and placed in
10% neutral buffered formalin until sectioning for
microscopic analysis. Aortic specimens were serially
sectioned into three or four rings and embedded
entirely in tissue blocks for hematoxylin and eosin
(H & E) staining. Histologic sections were then
reviewed by one person (O.T.) and scanned by a
computer assisted imaging device (CAS-200 Cell
Analysis System; Bacus Laboratory, Chicago, IL,
USA) for measurement of the vessel wall thickness.
The mean value of the vessel wall thickness from the
endothelial surface to the adventitia was recorded
from 10 different locations spanning the entire cross-
section.
Data analysis
The mean values of aortic wall thickness were first
normalized for overall body weight, since it has been
shown that larger mice generally exhibit larger vessel
wall thickness. Mean values of the aortic wall
thickness were compared using a standard Student
t-test with two independent samples using a two-
tailed comparison. Statistical significance was as-
sumed at p B /5%. Comparisons were made between
Sl/Sl
d and their normal littermates (  //  /) mice while
holding the diet type constant (i.e. high-fat and
K. N. Dileepan et al.
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control diet while holding the mouse strain constant
(i.e. mast cell-deficient and C57BL/6 mice) (Table 1).
Plasma concentrations of total cholesterol and trigly-
cerides were analyzed in a similar manner (Fig. 1). A
one-way analysis of variance was utilized to compare
mean values of the various hematological parameters
presented in Table 2. If a significant value of p
associated with the F-value was obtained, post hoc
testing by the method of Scheffe was used to identify
significantly different mean values.
Results
The mean body weight of Sl/Sl
d mice was signifi-
cantly lower than that of their age-matched normal
controls at the beginning and end of the experiment
irrespective of the type of diet consumed during the
course of the experiment. The mean body weight of
the normal mice that were fed the standard chow diet
was 29.79 /2.51 g (n  /8) compared with 21.09 /5.30 g
(n  /5; three mice died) for mast cell-deficient mice
fed the same diet. Similarly, the mean body weight of
the normal mice fed a high-fat diet was 27.29 /1.28 g
(n  /8) compared with 20.89 /4.50 g (n  /8) for mast
cell-deficient mice fed the same diet. In general, mast
cell deficient mice weighed approximately 7 /8 g less
than the corresponding control animals. The weight
gain during the 17 weeks of treatment was the same
for both Sl/Sl
d and normal littermates irrespective of
the diet they consumed.
Plasma lipids
The total plasma cholesterol concentrations for
normal and Sl/Sl
d mice fed a control diet or high-
fat diet are given in Fig. 1. As is evident there was
no difference in plasma cholesterol levels between
the normal and Sl/Sl
d mice (989 /3 mg/dl and
1029 /3 mg/dl, respectively). The 17-week high-fat
regimen resulted in a significant increase in plasma
cholesterol levels in both normal (2959 /5 mg/dl) and
the mast cell-deficient Sl/Sl
d mice (2879 /7 mg/dl).
The magnitude of the increase of total plasma
cholesterol was the same in both genotypes of
mice, suggesting that mast cells do not play a role
in plasma cholesterol homeostasis.
In comparison with the normal littermates, Sl/Sl
d
mice presented higher levels of plasma triglycerides
(Fig. 2). Consumption of the high-fat diet reduced
plasma triglyceride levels in both normal and mast
cell-deficient mice. Despite the presence of naturally
elevated plasma triglyceride levels in Sl/Sl mice,
feeding a high-fat diet was found to decrease these
levels (Fig. 2).
Aortic intima-media thickness
Mast cells are important constituents of the vascula-
ture and may participate in the development and
maintenance of vascular structure. Therefore, the
deficiency of mast cells may lead to structural
derangements of the vessel wall. To evaluate this
possibility and examine the influence of an athero-
genic diet on the vessel wall, aortic specimens were
serially sectioned into three or four rings and
embedded in tissue blocks for H & E staining. The
aortic rings stained with H & E stains from a
representative control mouse are shown in Fig. 3.
Histological sections were then reviewed and
scanned by a computer-assisted imaging device for
measurement of the vessel wall thickness (Table 1).
The mean value of the vessel wall thickness from
the endothelial surface to the adventitia was recorded
from 10 different locations spanning the entire cross-
section. When normalized for the body weights,
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FIG. 1. Plasma cholesterol levels in normal   //  / (solid bars)
and mast cell-deﬁcient Sl/Sl
d (hatched bars) mice maintained
on a normal diet or a high-fat diet. The results are the
mean9 /standard deviation of 10 animals per group except
for the Sl/Sl
d group fed a normal diet, which had ﬁve
animals. * Signiﬁcant (pB /0.05) increase in the mean value
within each strain when compared with mice eating a
normal diet for that strain.
Table 1. Aortic intima-media thickness in normal (  //  /)
and Sl/Sl
d mice maintained on a normal diet or a high-
fat diet
Genotype Diet Aortic intima
media-thickness
(mm)
Aortic-intima
media thickness
(mm/g of body
weight)
  //  / Normal 54.59 /4.8 (n  /8)
a 1.849 /0.16 (n  /8)
  //  / High-fat 58.09 /6.1 (n  /8) 2.159 /0.16 (n  /8)
b
Sl/Sl
d Normal 49.09 /4.1 (n  /5) 2.409 /0.41 (n  /5)
b
Sl/Sl
d High-fat 61.09 /6.8 (n  /8) 2.839 /0.35 (n  /8)
c,d
aMean value9 /standard deviation (number of animals evaluated).
bSignificantly (pB /0.05) greater than controls eating a normal diet.
cSignifcantly (pB /0.05) greater than controls eating a high-fat diet.
dSignificantly (pB /0.05) greater than mast cell-deficient (Sl/Sl
d) mice
eating a normal diet.
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for Sl/Sl
d mice than for their normal littermates (Table
1). Consumption of the high-fat diet resulted in an
increase in aortic intima-media thickness in both
normal and Sl/Sl
d mice. However, the increase in
aortic intima-media thickness in Sl/Sl
d mice fed the
high-fat diet was not different when compared with
those fed a normal chow diet.
Peripheral blood leukocyte counts
The total peripheral blood leukocyte counts and
hemoglobin levels were markedly lower in mast
cell-deficient Sl/Sl
d mice than their normal littermates
(Table 2). The differential counts of the peripheral
blood smear revealed no apparent difference in the
number of lymphocytes, eosinophils and basophils
between the two genotypes. However, the number of
monocytes and granulocytes were lower in Sl/Sl
d
mice. Interestingly, the consumption of a high-fat diet
normalized leukocyte counts, raised hemoglobin
levels, and increased the number of granulocytes
and monocytes in Sl/Sl
d mice.
Discussion
The results presented in this report demonstrate that
the aortic wall thickness of mast cell-deficient Sl/Sl
d
mice is 30% higher than their normal littermates,
when adjusted for body weights. The high-fat regi-
men increased the aortic wall thickness in both the
normal and Sl/Sl
d mice by 17% and 18%, respectively,
suggesting that neither stem cell factor deficiency or
mast cell deficiency resulted in enhanced changes in
vascular wall structure after a 17-week atherogenic
high-fat regimen. An intriguing finding of this study is
that the mast cell-deficient genotypes have elevated
levels of plasma triglycerides and normal levels of
levels of plasma cholesterol. The total peripheral
blood leukocyte counts and hemoglobin levels were
significantly lower in mast cell-deficient mice than
their normal littermates. The differential counts of the
peripheral blood smear revealed no apparent differ-
ence in the number of lymphocytes, eosinophils and
basophils between the two genotypes of mice.
However, the number of monocytes and granulo-
cytes were lower in Sl/Sl
d mice. Interestingly, the
consumption of a high-fat diet resulted in normal-
ization of total leukocyte counts as well as monocyte
and granulocyte counts in Sl/Sl
d mice.
It is well recognized that vascular structures are
typically well endowed with mast cells and they are
recruited to vessels undergoing atherosclerotic
changes.
14,15 It is not known whether mast cells are
recruited to vascular structures for the physiologic
maintenance of vascular integrity or to participate in a
pathologic event. The presence of mast cells in
atherosclerotic lesions could be important because
they release large amounts of chemotactic agents,
inflammatory molecules, histamine and proteases, all
of which are known to participate in endothelial cell
activation
24 27 and possibly the maintenance of
vascular integrity. Numerous studies have demon-
strated the role of mast cell proteases in mediating
extracellular matrix degradation through activation
and secretion of matrix metalloproteinases (MMPs).
28
On a weight and molar basis, enzymatically active
neutral proteases are the major exocytosed protein
constituents from activated mast cells.
4 Tryptases,
chymases, and carboxypeptidase A, in various com-
Table 2. Peripheral blood leukocyte counts and hemoglobin levels in normal and Sl/Sl/
d mice maintained on a normal diet or
a high-fat diet
Genotype Diet Leukocytes
(/ml)
Neutrophils
(%)
Lymphocytes
(%)
Monocytes
(%)
Eosinophils
(%)
Basophils
(%)
Hemoglobin
(g/dl)
  //  / Normal 61109 /1050 5.99 /0.9 86.59 /1.4 7.69 /1.5 0.79 /0.01 0.29 /0.01 15.59 /0.4
c
  //  / High-fat 74809 /1300 10.49 /4.8
a,b 80.59 /7.1 9.19 /2.8 0.79 /0.02 0.29 /0.01 14.19 /0.6
b
Sl/Sl
d Normal 47009 /1300 2.09 /1.0 93.09 /4.9 4.99 /3.9 0.79 /0.01 0.29 /0.02 6.49 /3.7
b
Sl/Sl
d High-fat 63109 /1900 5.99 /1.9 86.39 /4.6 7.99 /2.8 0.79 /0.03 0.29 /0.01 8.49 /1.5
a Significant (pB /0.05) difference compared with wild-type mice consuming a normal diet.
b Significant (pB /0.05) difference compared with Sl/Sl mice consuming a high-fat, high-cholesterol diet containing cholate.
c Significant (pB /0.05) difference compared with Sl/Sl mice consuming a normal diet.
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FIG. 2. Plasma triglyceride levels in normal (  //  /, solid bars)
and Sl/Sl
d (hatched bars) mice maintained on a normal diet
or a high-fat diet. The results are the mean9 /standard
deviation of 10 animals per group except for the Sl/Sl
d group
fed a normal diet, which had ﬁve animals. * Signiﬁcant (pB /
0.05) decrease in the mean value within each strain when
compared with mice eating a normal diet for that strain. #
Signiﬁcant (pB /0.05) increase in the mean value compared
with   //  / mice consuming a normal diet.
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teases stored in the granules of mast cells. Mast cell
tryptase and chymase are capable of activating the
latent forms of MMP-2,
29 MMP-9,
30 collagenase and
stromelysin.
31 Furthermore, stem cell factor has been
shown to modulate MMP-9 secretion by mast
cells.
32,33 Thus, a simple explanation for the in-
creased aortic wall thickness in Sl/Sl
d mice may be
mast cell deficiency-related absence of one or more
of these metalloproteinases that are required for the
maintenance and remodeling of vascular structure.
It is of interest that the Sl/Sl
d mice presented
elevated levels of plasma triglycerides and increased
aortic wall thickness. Hatanaka et al.
34 demonstrated
that approximately 70% of mast cell-deficient W/W
v
mice exhibited hypertriglyceridemia combined with
hypercholesterolemia. Fig. 2 demonstrates that the Sl/
Sl
d mice fed a normal diet had a greater than two-fold
increase in plasma triglyceride levels compared with
normal mice fed the same diet. The plasma choles-
terol levels (Fig. 1) were comparable in normal and
Sl/Sl
d mice but were elevated to the same magnitude
in both genotypes after the high-fat dietary regimen.
Recent reports suggest the involvement of mast cell
proteases in cardiovascular disease. The localization
of mast cells in the human heart
12 and the recognition
of mast cell chymase as a major pathway for the
generation of angiotensin II
7,18 support the role of
mast cells in both myocardial and vascular function. It
is possible that mast cell proteases play a role in the
clearance of plasma lipids via macrophage uptake
and degradation. To this effect mast cell chymase and
carboxypeptidase A are known to degrade LDL.
13,19
Again, it is of interest that the serum cholesterol levels
were unaltered in the mast cell-deficient Sl/Sl
d
genotypes. This finding together with the increased
triglyceride levels in Sl/Sl
d mice suggest that defi-
ciency of mast cell proteases, which are known to
degrade and augment triglyceride uptake by macro-
phages, may be responsible for the hypertriglycer-
idimia. The lipoprotein lipase and hepatic
triacylglycerol lipase in the plasma following an
injection of heparin were markedly lower in mast
cell-deficient mice compared with normal mice,
although the activity of both lipoprotein lipase in
the heart and adipose tissue and hepatic triacylgly-
cerol lipase in the liver were not decreased.
34 These
authors concluded that mast cell-deficient mice have
a genetic defect in one or more of the following: (1)
secretion of both lipases from their synthesizing cells,
(2) transport to the endothelium, and/or (3) anchor-
ing to the endothelial surface.
It is intriguing that for both normal and mast cell-
deficient mice, ingestion of a high-fat, high-choles-
terol diet containing 5% cholate (cholic acid) resulted
in a significant decrease in the plasma triglyceride
levels. This is consistent with the findings of Ikemoto
et al.,
35 who demonstrated that blood triglyceride
concentrations decreased significantly (pB /0.001)
when normal C57BL/6 mice were allowed to con-
sume a high-fat, high-cholesterol diet containing
cholate compared with control animals that ingested
a standard low-fat chow. Blood triglyceride concen-
trations decreased from approximately 90 mg/dl to 15
mg/dl when the mice consumed the diet for 9
weeks.
35 This trend was observed in our study as
well (Fig. 2). Moreover, this may potentially be the
reason that the mast cell-deficient mice fed a high-fat,
high-cholesterol diet containing cholate demon-
strated a significant decrease in their plasma trigly-
ceride compared with mast cell-deficient mice that
were allowed to consume a normal low-fat chow diet
(Fig. 2).
The mechanism by which the high-fat diet induced
granulopoeisis and erythropoeisis in Sl/Sl
d mice is
not known. Sl/Sl
d mast cell-deficient mice present an
abnormal microenvironment for hematopoeisis due
to defective production of stem cell factor by bone
marrow stromal cells.
36,37 Previous studies have
documented reduced numbers of natural killer cells,
FIG. 3. Images of aortic rings from a representative normal (  //  /) mouse depicting the technique used for the determination of
the intima media thickness. Aortic specimens were serially sectioned into three or four rings (A) and embedded entirely in
tissue blocks for H & E staining. Histological sections were reviewed and scanned by a computer-assisted imaging device for
measurement of the vessel wall thickness. The mean value of the vessel wall thickness from the endothelial surface to the
adventitia was recorded from 10 different locations spanning the entire cross-section. The cross lines (B) depict the
measurement of the vessel wall thickness in microns. Magniﬁcation  /200.
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mast cell-deficient mice.
38 In addition, mast cell
deficiency enhances nitric oxide synthase activity in
mouse jejunum
39 probably due to the lack of mast
cell granule mediators that serve to inhibit nitric
oxide production.
40 Increasing evidence now indi-
cates that interleukin-17 acts on bone marrow stroma
cells by inducing the release of granulocyte colony-
stimulating factor (G-CSF) and SCF, and Sl/Sl
d mice
are capable of secreting G-CSF in response to
interleukin-17.
41 It is not known whether mice
maintained on a high-fat diet had elevated levels
of interleukin-17 that in turn induced the secretion of
G-CSF. Bubnic et al.
42 demonstrated correction of
erythroid and mast cell deficiency in Sl/Sl
d mice by
stromal cell infusion. However, they failed to correct
for anemia in these animals. The present data
demonstrating the correction of granulopoesis with-
out the restoration of hemoglobin levels are in
agreement with their finding. To our knowledge,
this is the first evidence that demonstrates restoration
of granulopoiesis and erythropoeisis by a high-fat
diet. Taken together, the Sl/Sl
d mice demonstrate
increased aortic intima media thickness, hypertrigly-
ceridemia, anemia, mast cell deficiency and impaired
granulopoeisis. The derangements in the vascular
wall structure and lipid metabolism may be attributed
to the collective deficiency of stem cell factor and
mast cell proteases.
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